fig2

Engineered extracellular vesicles: pharmacological barriers, engineering strategies, and translational opportunities

Figure 2. Clinical progress of therapeutic modalities highlights the translational lag of extracellular vesicles. Created with BioRender. CAR-T: Chimeric antigen receptor T-cell; EV: extracellular vesicle; imDC: immature dendritic cell.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/